Peptic Ulcer Risk Factors: Who Is Most Vulnerable?
Populations at Highest Risk for Peptic Ulcer Disease
Peptic ulcers (gastric/duodenal) result from H. pylori infection, NSAIDs, or both, modulated by host factors. Risk is multiplicative, not merely additive.
Top Risk Factors (Ranked by Population Attributable Risk)
- H. pylori Infection: Causes 90% duodenal, 70–80% gastric ulcers. Prevalence: ~35% US adults; higher in immigrants, low SES, older cohorts. Eradication reduces recurrence from 60–80% to <10%.
- NSAID/ASA Use: Dose/duration dependent. RR 4–5× for ulcer complications. COX-2 selective + PPI reduces but doesn't eliminate risk.
- Age ≥65: Mucosal defense ↓ (mucus, bicarbonate, blood flow, prostaglandins); comorbidities, polypharmacy. Duodenal ulcer incidence peaks 50–70; gastric ulcer rises with age.
- Prior Ulcer History: Recurrence 50%+ at 1 yr if H. pylori not eradicated / NSAID continued.
- Anticoagulants / Antiplatelets (warfarin, DOACs, clopidogrel): Don't cause ulcers but increase bleeding severity if ulcer present. Combined with NSAID → synergistic risk.
- Corticosteroids: Alone modest risk; combined with NSAID → 15× ulcer risk.
- Smoking: Delays healing, increases recurrence, reduces prostaglandin synthesis. Current smokers 2× risk vs. never.
- Alcohol (>2 drinks/day): Mucosal irritant; synergizes with NSAIDs/H. pylori.
- Comorbidities: COPD, CKD, cirrhosis, transplant (immunosuppression), critical illness (stress ulcer prophylaxis indicated in ICU).
Protective Factors
- H. pylori eradication
- PPI co-therapy with NSAIDs (reduces ulcer risk 70–90%)
- COX-2 selective NSAID (celecoxib) + PPI for highest GI risk
- Smoking cessation
- Moderate alcohol
Clinical Pearls
- Test-and-treat for H. pylori before chronic NSAID initiation in high-risk patients.
- Stress ulcer prophylaxis (PPI/H2RA) only in ICU with risk factors (mechanical ventilation >48h, coagulopathy, sepsis)—not general wards.
- "Stress" (psychological) alone does not cause ulcers—but drives behaviors (smoking, alcohol, NSAID use) that do.
Risk stratification guides prophylaxis intensity. The elderly on multiple ulcerogenic meds with H. pylori are the highest-risk cohort.
Ulcers - Related Articles
- Abscess Packing Removal: Typical Timing and Clinical Judgment
- C-Section Scar Healing: What to Expect & How to Minimize Scars
- Understanding and Relieving Ulcer Pain: Causes & Remedies
- Natural Remedies for Peptic Ulcers: Relief & Healing
- Is Swallowing Pus Dangerous? Risks of Infection and Sepsis
- Crural Ulcers: Causes, Symptoms, Treatment, and Prevention
- Remicade (Infliximab): Uses, Dosage & What to Expect
